Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Caroline Cole Block, M.D.

Concepts (128)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Breast Neoplasms220211460.320 Why?
Aromatase Inhibitors220245110.260 Why?
Breast Neoplasms112024210170.260 Why?
Dihydrouracil Dehydrogenase (NADP)12024170.230 Why?
Acupuncture, Ear12022130.200 Why?
Cyclin-Dependent Kinase 6120243450.190 Why?
Filgrastim120201320.180 Why?
Cyclin-Dependent Kinase 4120245550.180 Why?
Receptors, Progesterone1202411300.160 Why?
Receptors, Estrogen2202422100.160 Why?
Pyridines2202428590.140 Why?
Carcinoma, Neuroendocrine120203460.140 Why?
Receptor, erbB-22202425530.130 Why?
Paclitaxel2202117280.130 Why?
Interdisciplinary Communication120219310.120 Why?
Antineoplastic Combined Chemotherapy Protocols32024117090.120 Why?
Polyethylene Glycols1202011890.120 Why?
Cyclophosphamide1202022180.120 Why?
Piperazines1202425110.110 Why?
Doxorubicin1202022090.110 Why?
Premenopause1201410380.090 Why?
Medical Oncology2202123120.090 Why?
Tamoxifen120149630.080 Why?
Nitriles120149570.080 Why?
Triazoles120149020.080 Why?
Thyroid Neoplasms1202023320.070 Why?
Spinal Cord Compression219992340.070 Why?
Benzimidazoles120118550.070 Why?
Antineoplastic Agents, Hormonal1201415300.060 Why?
Mammography1201224270.050 Why?
Premedication120212470.050 Why?
Phthalazines120233820.050 Why?
Antimetabolites, Antineoplastic120246380.040 Why?
Female1820243903230.040 Why?
Neoplasm Recurrence, Local3202392730.040 Why?
Fluorouracil1202416310.040 Why?
Proto-Oncogene Proteins c-ret120202250.040 Why?
Nausea120226770.040 Why?
Vomiting120226510.040 Why?
BRCA2 Protein120237980.040 Why?
Venous Thromboembolism1201118550.040 Why?
Early Detection of Cancer1201232110.040 Why?
Models, Statistical1201250700.040 Why?
Feasibility Studies2202251990.040 Why?
Practice Guidelines as Topic2201273780.040 Why?
BRCA1 Protein1202311470.030 Why?
Risk Assessment42012238840.030 Why?
Humans1920247584060.030 Why?
Thyroidectomy120209020.030 Why?
Germ-Line Mutation1202318400.030 Why?
Bone Marrow Transplantation2199226930.030 Why?
Lymphatic Metastasis1202129430.030 Why?
Pedigree1202045780.030 Why?
American Cancer Society12012660.030 Why?
Aged720241682180.030 Why?
Middle Aged920242195680.030 Why?
Spinal Neoplasms119997160.030 Why?
Antithrombin Proteins12011100.020 Why?
Ovarian Neoplasms1200948760.020 Why?
Ovariectomy120146100.020 Why?
Leukopenia119922110.020 Why?
Survival Analysis22021101120.020 Why?
Economics, Pharmaceutical12011870.020 Why?
Anemia, Hemolytic119921630.020 Why?
Neoplasm Metastasis1202149010.020 Why?
Biopsy1202167680.020 Why?
Combined Modality Therapy1202185300.020 Why?
Spinal Cord Diseases119922930.020 Why?
Risk Management120125570.020 Why?
Aged, 80 and over32024586830.020 Why?
Retrospective Studies52023801680.020 Why?
Gonadotropin-Releasing Hormone1201411530.020 Why?
Multivariate Analysis12021120960.020 Why?
Adult820242199350.020 Why?
Protein Kinase Inhibitors1202456290.020 Why?
Disease Progression12024134680.020 Why?
Proportional Hazards Models12021124400.020 Why?
Needs Assessment1201211410.020 Why?
Prospective Studies22021541370.020 Why?
Chemotherapy, Adjuvant1201435270.020 Why?
Medical History Taking120097720.020 Why?
Magnetic Resonance Imaging12012362840.020 Why?
Survival Rate22014127210.010 Why?
Thrombocytopenia1199211710.010 Why?
Body Mass Index12020128760.010 Why?
Case-Control Studies12020220290.010 Why?
Guideline Adherence1201222150.010 Why?
Phylogeny1200927740.010 Why?
Pandemics1202186110.010 Why?
Patient Selection1201242440.010 Why?
Neoplasm Staging12014111520.010 Why?
United States22021721360.010 Why?
Genetic Predisposition to Disease22012177680.010 Why?
Patient Education as Topic1200923070.010 Why?
Risk Factors32020738090.010 Why?
Cost-Benefit Analysis1201154840.010 Why?
Child, Preschool12020420620.010 Why?
Prognosis22014295570.010 Why?
Follow-Up Studies22014390590.010 Why?
Genetic Testing1200935300.010 Why?
Physician-Patient Relations1200932420.010 Why?
Cohort Studies22012412560.010 Why?
Male520243587470.010 Why?
Logistic Models21999132760.010 Why?
Young Adult12020588080.010 Why?
Mass Screening1200954270.010 Why?
Medical Records1199814060.010 Why?
Child12020798180.010 Why?
Blotting, Southern119927770.010 Why?
Polymorphism, Restriction Fragment Length119927630.010 Why?
Neurology119997780.010 Why?
Splenectomy119923910.010 Why?
Diagnosis, Differential21998129510.010 Why?
Quality of Life12011132850.010 Why?
Forecasting1199929230.010 Why?
Pain Measurement1199835270.000 Why?
Fluorescent Antibody Technique1199224700.000 Why?
Patient Care Team1199925040.000 Why?
Immunoglobulins, Intravenous119926640.000 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive119926850.000 Why?
Prednisone1199215650.000 Why?
Tomography, X-Ray Computed21999205000.000 Why?
Radiology1199921020.000 Why?
Palliative Care1199935700.000 Why?
Chromosome Mapping1199246240.000 Why?
Flow Cytometry1199258640.000 Why?
Leukemia, Myeloid, Acute1199235990.000 Why?
Adolescent11999878920.000 Why?
Block's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (128)
Explore
_
Co-Authors (53)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.